Lupin profits on settling all lawsuits
Thursday, December 18, 2008 11:12 amLupin’s shares have gained by 2% to Rs565 after the company said that it settled all lawsuits that tried to block it from selling a generic version of Schering-Plough Corp.’s Clarinex allergy medicine.
The stock has touched an intra-day high of Rs585 and a low of Rs555 and has recorded volumes of over 8,000 shares on NSE.
